Greg Yothers

2001–2026 年に発表

85
論文数
23,690
被引用数
56
h 指数
81
i10 指数

被引用数

Greg Yothers の年別被引用数1974 年: 被引用 1 件1979 年: 被引用 1 件1993 年: 被引用 1 件2001 年: 被引用 1 件2002 年: 被引用 3 件2003 年: 被引用 18 件2004 年: 被引用 25 件2005 年: 被引用 33 件2006 年: 被引用 107 件2007 年: 被引用 151 件2008 年: 被引用 165 件2009 年: 被引用 202 件2010 年: 被引用 229 件2011 年: 被引用 232 件2012 年: 被引用 221 件2013 年: 被引用 207 件2014 年: 被引用 190 件2015 年: 被引用 221 件2016 年: 被引用 189 件2017 年: 被引用 186 件2018 年: 被引用 164 件2019 年: 被引用 566 件2020 年: 被引用 593 件2021 年: 被引用 520 件2022 年: 被引用 512 件2023 年: 被引用 388 件2024 年: 被引用 746 件2025 年: 被引用 345 件2026 年: 被引用 11 件1975〜1978 年は被引用が無いため表示していません1980〜1992 年は被引用が無いため表示していません1994〜2000 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,303 件、この内訳の 26.1%中国: 引用元論文 701 件、この内訳の 8%イギリス: 引用元論文 568 件、この内訳の 6.4%イタリア: 引用元論文 535 件、この内訳の 6.1%ドイツ: 引用元論文 406 件、この内訳の 4.6%フランス: 引用元論文 394 件、この内訳の 4.5%カナダ: 引用元論文 338 件、この内訳の 3.8%スペイン: 引用元論文 318 件、この内訳の 3.6%日本: 引用元論文 271 件、この内訳の 3.1%オランダ: 引用元論文 248 件、この内訳の 2.8%スイス: 引用元論文 231 件、この内訳の 2.6%オーストラリア: 引用元論文 227 件、この内訳の 2.6%
0%26.1%その他 25.8%

分野

  • Medicine68.2%
  • Biochemistry, Genetics and Molecular Biology25.5%
  • Immunology and Microbiology1.2%
  • Computer Science1.1%
  • Health Professions0.8%
  • Materials Science0.6%
  • その他2.6%

トピック

  • HER2/EGFR in Cancer Research6.7%
  • Colorectal Cancer Treatments and Studies6.4%
  • Breast Cancer Treatment Studies6%
  • Colorectal Cancer Surgical Treatments5.7%
  • Genetic factors in colorectal cancer4.8%
  • Cancer Treatment and Pharmacology3.4%
  • その他67%

共著者

全論文

検索で開く
  1. Adjuvant Olaparib for Patients with BRCA1 - or BRCA2 -Mutated Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Joseph P. Costantino, Amal Arahmani, Norman Wolmark, Eleanor McFadden, Vassiliki Karantza, Sunil R. Lakhani, Greg Yothers, Christine Campbell, Charles E. Geyer - New England Journal of Medicine 2021 被引用: 1,665

  2. Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sunil R. Lakhani, W Janni, Barbro Linderholm, T.-W. Liu, Niklas Loman, Larissa A. Korde, Sibylle Loibl, Peter C. Lucas, Frederik Marmé, E. Martinez de Dueñas, Robin McConnell, Kelly‐Anne Phillips, Martine Piccart, Giovanna Rossi, Rita K. Schmutzler, Elżbieta Senkus, Zhi-Ming Shao, Priyanka Sharma, Christian F. Singer, Tanja Španić, Elmar Stickeler, Masakazu Toi, Tiffany A. Traina, Giuseppe Viale, Gabriele Zoppoli, Y.H. Park, Rinat Yerushalmi, Huan Yang, D. Pang, Kyung Hae Jung, Audrey Mailliez, Zhaoqing Fan, Isabelle Tennevet, J. Zhang, T. Nagy, Gabe S. Sonke, Qiuhong Sun, Marina Parton, Marco Colleoni, Marcus Schmidt, Adam Brufsky, W. Razaq, Bella Kaufman, David Cameron, Christine Campbell, Andrew Tutt, P. Sevelda, Ferdinand Haslbauer, Monika Penzinger, Leopold Öhler, Christoph Tinchon, Richard Greil, Sonja Heibl, Rupert Bartsch, Viktor Wette, Christian F. Singer, Claudia Pasterk, Ruth Helfgott, Gunda Pristauz-Telsnigg, Herbert Stöger, A. Weltermann, Daniel Egle, I. Thiel, David Fuchs, Holger Rumpold, Kathrin Strasser‐Weippl, Beate Rautenberg, Volkmar Müller, Marcus Schmidt, Stefan Paepke ほか 509 名 - Annals of Oncology 2022 被引用: 447

  3. Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2005 被引用: 5,353

  4. ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Fang‐Shu Ou, Laura Porter, Kanwal Raghav, Deborah Schrag, Aaron J. Scott, Qian Shi, John H. Strickler, Alan P. Venook, Rona Yaeger, Greg Yothers, Y. Nancy You, Jason A. Zell, Scott Kopetz - Nature Reviews Clinical Oncology 2020 被引用: 365

  5. Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Toru Watanabe, Greg Yothers, Ke‐Da Yu, Richard Berry, Clare Boddington, Mike Clarke, Christina Davies, Lucy Davies, Frances Duane, Vaughan Evans, Jo Gay, Lucy Gettins, Jon Godwin, Sam James, Hui Lui, Zulian Lui, Elizabeth MacKinnon, Gurdeep Mannu, Theresa McHugh, Philip Morris, Simon Read, Ewan Straiton, Aman U. Buzdar, Vera J. Suman, Kelly K. Hunt, Robert Leonard, Janine Mansi, Catherine Delbaldo, Pascal Piedbois, Emmanuel Quinaux, Christian Fesl, Michael Gnant, Lidija Sölkner, Guenther G. Steger, Hans Petter Eikesdal, Per Eystein Lønning, Valerie Bée, Helena Fung, John R. Mackey, Miguel Martín, Michael F. Press, Evandro de Azambuja, Richard D. Gelber, Meredith M. Regan, Angelo Di Leo, Veerle Van Dooren, J.-M. Nogaret, John M.S. Bartlett, Bingshu E. Chen, Karen A. Gelmon, Paul E. Goss, Mark N. Levine, Wendy R. Parulekar, Kathleen I. Pritchard, Lois E. Shepherd, Donald A. Berry, Constance Cirrincione, Lawrence N. Shulman, Eric P. Winer, Rebecca Gelman, Jay R. Harris, Craig Henderson, Charles L. Shapiro, Peer Christiansen, Marianne Ewertz, Henning T. Mouridsen, Elise Van Leeuwen, Sabine C. Linn, Annelot G.J. van Rossum, Harm van Tinteren ほか 136 名 - The Lancet 2023 被引用: 189

  6. Use of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2021 被引用: 188

  7. Evidence for Cure by Adjuvant Therapy in Colon Cancer: Observations Based on Individual Patient Data From 20,898 Patients on 18 Randomized Trials

    著者: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2009 被引用: 676

  8. Microsatellite Instability in Patients With Stage III Colon Cancer Receiving Fluoropyrimidine With or Without Oxaliplatin: An ACCENT Pooled Analysis of 12 Adjuvant Trials

    著者: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 被引用: 172

  9. Oxaliplatin Combined With Weekly Bolus Fluorouracil and Leucovorin As Surgical Adjuvant Chemotherapy for Stage II and III Colon Cancer: Results From NSABP C-07

    著者: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2007 被引用: 1,053

  10. Seven-Year Follow-Up Assessment of Cardiac Function in NSABP B-31, a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel (ACP) With ACP Plus Trastuzumab As Adjuvant Therapy for Patients With Node-Positive, Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2012 被引用: 519

  11. Different prognostic values of KRAS exon 2 submutations and BRAF V600E mutation in microsatellite stable (MSS) and unstable (MSI) stage III colon cancer: an ACCENT/IDEA pooled analysis of seven trials

    著者: , , , , , , , , , , , , , , , - Annals of Oncology 2023 被引用: 43

  12. Phase II results of circulating tumor DNA as a predictive biomarker in adjuvant chemotherapy in patients with stage II colon cancer: NRG-GI005 (COBRA) phase II/III study.

    著者: , , , , , , , , , , , , , - Journal of Clinical Oncology 2024 被引用: 38

  13. Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial

    著者: , , , , , , , , , , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2015 被引用: 328

  14. Anthracyclines in Early Breast Cancer: The ABC Trials—USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology)

    著者: , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 被引用: 288

  15. Preoperative Multimodality Therapy Improves Disease-Free Survival in Patients With Carcinoma of the Rectum: NSABP R-03

    著者: , , , , , , , , , , - Journal of Clinical Oncology 2009 被引用: 942

  16. CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer

    著者: , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2016 被引用: 481

  17. Oxaliplatin As Adjuvant Therapy for Colon Cancer: Updated Results of NSABP C-07 Trial, Including Survival and Subset Analyses

    著者: , , , , , , - Journal of Clinical Oncology 2011 被引用: 662

  18. DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy

    著者: , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2011 被引用: 529

  19. Capecitabine and Oxaliplatin in the Preoperative Multimodality Treatment of Rectal Cancer: Surgical End Points From National Surgical Adjuvant Breast and Bowel Project Trial R-04

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2014 被引用: 441

  20. Neoadjuvant Rectal (NAR) Score: a New Surrogate Endpoint in Rectal Cancer Clinical Trials

    著者: , , - Current Colorectal Cancer Reports 2015 被引用: 166

  21. Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab As Adjuvant Therapy in Node-Positive, Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: NSABP B-31

    著者: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2005 被引用: 807

  22. Phase III Trial Assessing Bevacizumab in Stages II and III Carcinoma of the Colon: Results of NSABP Protocol C-08

    著者: , , , , , , , , , , , , , , - Journal of Clinical Oncology 2010 被引用: 594

  23. Bevacizumab in Stage II-III Colon Cancer: 5-Year Update of the National Surgical Adjuvant Breast and Bowel Project C-08 Trial

    著者: , , , , , , - Journal of Clinical Oncology 2012 被引用: 208

  24. Clinical Outcome From Oxaliplatin Treatment in Stage II/III Colon Cancer According to Intrinsic Subtypes

    著者: , , , , , , , , , , , - JAMA Oncology 2016 被引用: 174